We therefore acknowledge the possibility of some protective effects of obesity, as recently postulated by the increased levels of plasminogen activator inhibitor 1 in obese patients with MI, which we were not able to test in this analysis [57]. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.